Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-02-13
2010-06-08
Jiang, Shaojia Anna (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07732583
ABSTRACT:
Novel glycolipid derivatives, where the substituent of the sphingosine base part is a short carbon chain alkyl group, substituted or unsubstituted cycloalkyl group, substituted or unsubstituted aryl group or substituted or unsubstituted aralkyl group and efficient synthetic methods for practical mass production of the same and intermediates useful for the synthesis of these compounds.Glycolipids having the formula (I):where R3indicates a substituted or unsubstituted C1to C7linear alkyl group, substituted or unsubstituted cycloalkyl group, substituted or unsubstituted aryl group, or substituted or unsubstituted aralkyl group and R8indicates a substituted or unsubstituted C1to C35alkyl group, substituted or unsubstituted aryl group or substituted or unsubstituted aralkyl group are chemically synthesized.
REFERENCES:
patent: 5936076 (1999-08-01), Higa et al.
patent: 0 988 860 (2000-03-01), None
patent: 93/05055 (1993-03-01), None
patent: 94/09020 (1994-04-01), None
patent: WO 98/16235 (1998-04-01), None
patent: 03/016326 (2003-02-01), None
Figueroa-Perez et al. Carbohydrate Research 328 (2000) 95-102.
Wild et al. Liebigs Ann. 1995, 755-764.
Schmidt et al. Carbohydrate Research vol. 174, Mar. 15, 1988, abstract.
Kobayashi et al. Tetrahedron Letters, vol. 35, No. 51, pp. 9573-9576.
Toshima et al. Chem. Rev. 1993, 93, 1503-1531.
Miyamoto, K. et al., “A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells”, Nature, Oct. 4, 2001, vol. 413, No. 6855, pp. 531-534.
Ayad, T et al., “A new diorganiozinc-based enantio-selective access to truncated D-ribo-phytosphingosine”, Tetrahedron Letters, Jan. 13, 2003, vol. 44, Issue 3, pp. 579-582.
Morita, M. et al., “Structure-Activity Relationship of α-Galactosylceramides against B16-Bearing Mice”, Journal of Medicinal Chemistry, Jun. 9, 1995, vol. 38, No. 12, pp. 2176-2187.
Brossay, L. et al., “Cutting Edge: Structural Requirements for Galactosylceramide Recognition by CDI-Restricted NK T Cells”, Journal of Immunology, Nov. 15, 1998, vol. 161, No. 10, pp. 5124-5128.
Chiu, H., et al., “A Facile Synthesis of Phyto-sphingosine from Diisopropylidepe-D-mannofuranose”, Journal of Organic Chemistry, Jul. 11, 2003, vol. 68, No. 14, pp. 5788-5791.
Kawano, T. et al., “Natural killer-like non-specific tumor cell lysis medicated by specific ligand-activated Vα14 NKT cells”, Proceedings of the Natural Academy of Sciences of the USA, May 12, 1998, vol. 95, No. 10, pp. 5690-5693.
Kidd, P. PhD., Th1/Th2 Balance: The Hypothesis, its Limitations, and Implications for Health and Disease,: Alternative Medicine Review, vol. 8, No. 3, 2003, pp. 223-246.
Yamamura, Takashi, “Notoshinkei,” vol. 53, 2001, pp. 707-713.
Murata et al., “Total Synthesis of an Immunosuppressive Glycolipid, (2S,3S,4R)-1-O- (α-D-Galactosyl)-2-tetracosanoylamino-1,3,4-nonanetroil”,J. Org. Chem., vol. 70, No. 6, 2005, pp. 2398-2401.
Miyake, S. “NKT Saibo to Jikkenteki Jikio Men'ekisei No Sekizuien”, Inflammation & Immunology, Aug. 20, 2002, vol. 10, No. 5, pp. 501-506.
Miyake, S. “NKT Saibo Toshishitsu Ligand ni yoru Jiko Men'ekisei Shikkan Seigo”, Annual Review Men'eki 2003, Dec. 5, 2002, pp. 71-77.
Costantino et al., “Immunomodulating Glycophingolipids: an Efficient Synthesis of a 2′-deoxy-α-galactosyl-GSL”,Tetrahedron, Elsevier Science Publishers, Amsterdam, NL, vol. 58, No. 2, Jan. 7, 2002, pp. 369-375, XP004330613.
Akimoto et al., “Synthesis and Stereochemistry of Agelasphin-9b”,Tetrahedron Letters, vol. 34, No. 35, 1993, pp. 5593-5596, XP002554487.
Schmidt et al., “Synthesis ofD-ribo-andL-Iyxo-Phytosphingosine: Transformation Into the Corresponding Lactosyl-Ceramides”,Carbohydrae Research, Elsevier Science Publishers B. V., Amsterdam, vol. 174, 1998, pp. 169-179, XP002554488.
Plettenburg et al., “Synthesis of α-Galactosyl Ceramide, A Potent Immunostimulatory Agent”,J. Org. Chem., vol. 67, No. 13, 2002, pp. 4559-4564, XP002554489.
Annoura Hirokazu
Murata Kenji
Yamamura Takashi
Bland Layla
Drinker Biddle & Reath LLP
Japan as represented by President of National Center of Neurolog
Jiang Shaojia Anna
LandOfFree
Glycolipids and synthetic method thereof as well as their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycolipids and synthetic method thereof as well as their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycolipids and synthetic method thereof as well as their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201279